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G. Chad Hughes, MDn, Nicholas D. Andersen, MDn, and Richard L. McCann, MD†Medical therapy remains the primary treatment foruncomplicated type B aortic dissection, as described
using the Stanford classiﬁcation. However, 20%-40% of
patients with uncomplicated type B dissection would
eventually require surgical intervention owing to complica-
tions of chronic (42 weeks from symptom onset)
dissection. The most common complication is aneurysmal
degeneration of the false lumen due to persistent false lumen
pressurization and blood ﬂow through proximal and distal
fenestrations or reentry tears.1,2 Thoracic endovascular aortic
repair (TEVAR) has received attention as a less invasive
treatment option for chronic type B dissection given the
reduced procedural morbidity caused by it compared with
open surgery.3 However, the therapeutic rationale of
endoluminal therapy for the treatment of chronic false
lumen aneurysms is distinctly different than for non-
dissected, degenerative aneurysms given that complete
proximal and distal aneurysm seal is often not achieved.
Instead, the goal of endovascular therapy is to reduce or
eliminate antegrade ﬂow within the false lumen by covering
the primary tear. Elimination of antegrade blood ﬂow into
the false lumen is intended to promote false lumen
thrombosis, depressurization, and eventual reverse aortic
remodeling with aneurysm shrinkage, and thereby prevent
aortic rupture.
Critics of TEVAR for chronic type B dissection posit that
endovascular therapy would ultimately fail because of thematter r 2013 Elsevier Inc. All rights reserved.
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0. E-mail: gchad.hughes@duke.edupresence of uncovered distal fenestrations which would
allow for continued backﬁlling and pressurization of the false
lumen. In addition, the thickened chronic intimal dissection
ﬂap may not immediately reapproximate to the native aortic
wall and is thought to be less amenable to reverse
remodeling.4 Despite these concerns, reports from multiple
centers have demonstrated successful false lumen thrombo-
sis, depressurization, reverse remodeling, and aneurysm
shrinkage in most of chronic type B dissection patients
treated by TEVAR at midterm follow-up.1,5-8 However,
treatment failures occur in approximately 8% of patients,
suggesting some anatomical dissection conﬁgurations may
be poorly suited for endovascular repair.9 The comparative
long-term freedom from reintervention and aorta-speciﬁc
survival between patients treated by TEVAR and open
surgery also remain to be seen.
The use of TEVAR for the treatment of chronic type B
dissection therefore remains in a period of evolution and
discovery. Nonetheless, at our institution, TEVAR has become
the preferred treatment for chronic type B dissection with
associated descending thoracic aneurysm in patients with
suitable anatomy owing to the improved procedural and
midterm outcomes identiﬁed thus far.1,2 Indications for repair
in asymptomatic patients include rapid aneurysm enlargement
deﬁned as45-mm growth in 12 months or absolute size. For
fusiform aneurysms, this includes a diameter of 5.5 cm or
more, whereas for saccular aneurysms, a protrusion of 2 cm or
more beyond the aortic wall is an indication for treatment in
the absence of symptoms. Conventional open surgery is
reserved for patients with connective tissue disease or anatomy
unsuitable for TEVAR, such as those with thoracoabdominal,
rather than isolated thoracic, aneurysms. This report illustrates
our operative techniques for TEVAR in a classic chronic type B
dissection patient with aneurysmal false lumen degeneration
conﬁned to the upper descending thoracic aorta adjacent to the
primary tear (Figs. 1-14).101
Figure 1 The appearance of a typical chronic type B dissection with aneurysmal degeneration of the false lumen. The dissection extends from
the left subclavian artery (LSCA) to the infrarenal aorta. However, the aneurysm is conﬁned to the proximal descending thoracic aorta adjacent
to the site of the primary tear. The false lumen is pressurized and patent owing to blood ﬂow entering proximally at the primary tear and
exiting through distal fenestrations in the infrarenal aorta. The chronic dissection ﬂap is mature and thickened.
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Figure 2 (A) Appearance of the chronic type B dissection and aneurysm on 3-dimensional computed tomography angiography (CTA)
demonstrating the aneurysm adjacent to the primary tear. This is the type of patient we feel is best suited to treatment with TEVAR.
(B) Sagittal CTA reconstruction image demonstrating the location of the primary tear with a visible jet of contrast passing from the true lumen
into the large aneurysmal false lumen of the proximal descending thoracic aorta. (C) The proximal descending thoracic aortic aneurysm
diameter measures 6.4 cm in maximal dimension and therefore meets criteria for elective repair.
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Figure 3 A TEVAR-based approach to chronic type B dissection with aneurysm should not be utilized if the patient has a thoracoabdominal
aortic aneurysm rather than an isolated descending thoracic aneurysm arising adjacent to the primary tear. We prefer the diameter of the distal
descending thoracic aorta to be ≤42 mm when utilizing TEVAR for chronic type B dissection with aneurysm, as shown in the case above.
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Figure 4 Another consideration with regards to patient selection for TEVAR is whether or not the LSCA arises entirely from the true lumen. The
most favorable anatomical scenario for utilizing a TEVAR-based approach to chronic dissection with aneurysm is when the tear originates
distal to the origin of the LSCA. If the tear involves the LSCA origin, the aortic false lumen may continue to be perfused by retrograde ﬂow in
the dissected portion of the LSCA. In the typical case in which the tear originates just distal to the LSCA origin, the LSCA would need to be
covered by the endograft to gain adequate proximal landing zone length, and the need for concomitant LSCA revascularization is based on our
previously published guidelines for a selective revascularization strategy.10 If the tear involves the LSCA origin, the artery would need to be
occluded in its proximal extent, usually using endovascular means, to prevent continued false lumen perfusion via the vessel. This must entail
occlusion of both the true and false lumens of the artery in the event the LSCA is itself dissected. Revascularization of the distal LSCA is then
considered if indicated. LSCA ¼ left subclavian artery.
Endovascular repair of chronic type B aortic dissection 105
Figure 5 Another consideration with regards to patient selection is the number of visceral vessels (celiac artery, superior mesenteric artery, and
renal arteries) that are fed from the true rather than false lumen. The ideal patient has all 4 visceral vessels arising from the true lumen such
that no fenestrations exist at the level of the visceral segment to provide continued false lumen perfusion. Patients with less than 4 vessels
arising from the true lumen, which is the usual scenario, may also be treated using endovascular means as long as the distal descending
thoracic aorta is not dilated as outlined previously. SMA ¼ superior mesenteric artery; a ¼ artery.
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Figure 6 The proximal landing zone should be considered as all aorta proximal to the primary tear, whether dissected or not. In the case
shown, part of the proximal landing zone is dissected and part is not. The length of the proximal landing zone is 60 mm as demonstrated in
the upper left 2 panels. This is measured from immediately proximal to the primary tear to immediately distal to the left common carotid
artery. The minimal acceptable proximal landing zone length is 2 cm proximal to the primary tear. The proximal landing zone diameter
typically varies greatly, as demonstrated here, given that it usually contains nondissected (bottom left ﬁgure) and dissected (bottom middle
ﬁgure) aorta. We use the average diameter measurement in the nondissected portion of the aorta in the arch (usually zone 2; bottom left
ﬁgure) for determining the diameter of endograft to be utilized. Further, we typically use the minimum recommended oversizing using the
manufacturer-provided sizing guides for the various commercially available devices.
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Figure 7 Blowup of the bottom left ﬁgure from Figure 6 demonstrating the average diameter of the nondissected zone 2 proximal landing zone
as measured using curved planar reformat technique on a 3-dimensional workstation.
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Figure 8 When deciding on the extent of distal aortic coverage or pavement with TEVAR, the preoperative CTA should be studied carefully to
detect distal fenestrations between the true and false lumens in the thoracic aorta within the chest. These typically arise at the level of
intercostal vessel origins and should be covered by the endograft to prevent continued false lumen perfusion. One should have a low threshold
to pave most of the descending thoracic aorta down to the celiac axis in chronic dissection cases to ensure that all distal fenestrations have been
covered. CTA, computed tomography angiography.
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Figure 9 The distal landing zone would generally be entirely within dissected aorta. Distal landing zone diameters are measured only for the
true lumen as shown above in the left panel demonstrating the average diameter of the dissected distal landing zone as measured using the
curved planar reformat technique. As the endograft would only occupy the true lumen of the aorta, as demonstrated in the post-TEVAR
intravascular ultrasound (IVUS) image to the right, only the true lumen diameter is relevant for sizing. As such, excessive oversizing relative to
the true lumen diameter should be avoided, especially with the higher radial force devices, as there exists the possibility of creating new stent
graft–induced entry tears which would continue to feed the false lumen and lead to failure of an endovascular approach.11 As such, we have
evolved to favor use of tapered devices in this scenario if feasible or lower radial force devices such as the newer GORE C-TAG (W.L. Gore and
Associates, Flagstaff, AZ) device or both. We also typically avoid balloon molding of distal seal zones for this reason. Finally, unlike acute type
B dissection where distal to proximal endograft deployment is avoided, distal to proximal deployment may be utilized in the chronic setting if
necessary such as when placing a smaller GORE C-TAG device distally within the dissected true lumen followed by larger device(s)
proximally.
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Figure 10 Case planning concludes with an assessment of the access vessels. Oftentimes, the dissection may extend to involve 1 or both of the
iliofemoral systems. In the event of unilateral iliofemoral dissection as shown above, we prefer an open femoral cut down on the nondissected
side for large bore introducer sheath placement. Obtaining true lumen wire access in a dissected iliofemoral system usually requires IVUS
guidance. Often a technique is required in which a wire is passed from a right brachial access (proximal to the tear) into the iliac system and
snared from the groin to achieve through-and-through true lumen access. Whatever technique is used, IVUS documentation of true lumen
wire and device position is mandatory to avoid deploying the stent graft in the wrong lumen. IVUS, intravascular ultrasound.
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Figure 11 The patient is placed in a supine position on the hybrid operating room table and prepped from the chin to the midthighs. The right
arm is prepped into the sterile ﬁeld in the event that a right brachial approach is required to gain true lumen access. Routine spinal cord
management includes neurophysiological intraoperative monitoring with somatosensory and motor-evoked potentials and preoperative
lumbar drain placement for patients at high risk of spinal cord injury based on previously published risk factors (age, comorbidities, prior
aortic interventions, and planned extensive aortic coverage). Clinical or electrophysiological evidence of spinal cord ischemia during the
operation is treated by blood pressure augmentation, cerebrospinal ﬂuid drainage, and postoperative lumbar drain placement if not already
present.12,13
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Figure 12 IVUS is mandatory intraoperatively in all cases to ensure true lumen wire access (left panel) to avoid deployment of endografts in the
false lumen with disastrous results. Further, IVUS can be used to conﬁrm preoperative CTA measurements. IVUS should be used after
endograft deployment to ensure that the endografts are well expanded in the distal smaller true lumen. Further, IVUS and intraoperative
transesophageal echocardiography (TEE, right panel) assessment of the ascending aorta immediately after TEVAR are mandatory to ensure
that retrograde type A dissection has not occurred given the increased incidence of this complication when performing TEVAR for a dissection
indication.14 CTA ¼ computed tomography angiography; IVUS ¼ intravascular ultrasound.
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Figure 13 In the case depicted, the endograft was deployed in the true lumen with adequate zone 2 proximal landing zone in nondissected
aorta. The LSCA has been covered without revascularization. The entire descending thoracic aorta has been paved to cover the primary tear as
well as distal fenestrations, and the distal landing zone terminates in dissected aorta just proximal to the celiac axis. Dissected, but
nonaneurysmal, aorta continues into the infrarenal aorta. A ﬁnal examination of the aortic root by IVUS and TEE is performed before case
completion to inspect for retrograde type A dissection. LSCA ¼ left subclavian artery; IVUS ¼ intravascular ultrasound; TEE ¼
transesophageal echocardiography.
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Figure 14 Careful surveillance with clinical examination and CTA at 1, 6, and 12 months postoperatively and annually thereafter is required to
conﬁrm successful aneurysm treatment and to assess for endoleak and device failure. In the case shown above, the 4-year post-TEVAR CTA
demonstrates reverse remodeling of the stented portion of the descending thoracic aorta, with obliteration of the false lumen and no residual
aneurysm. The maximum aortic diameter now measures 4 cm, decreased from 6.4 cm preoperatively (Fig. 2). CTA ¼ computed tomography
angiography.
Endovascular repair of chronic type B aortic dissection 115
G.C. Hughes, N.D. Andersen, and Richard L. McCann116Conclusions
TEVAR for chronic type B dissection is technically feasible
and is associated with reduced procedural morbidity when
compared with conventional open repair. Midterm out-
comes in properly selected patients are favorable,1,2 with
most experiencing thoracic false lumen thrombosis, reverse
remodeling, and aneurysm shrinkage. However, long-term
outcomes and the identiﬁcation of patients who are prone to
failure with endovascular therapy await further elucidation.References
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